U.S. Banks Stock News

NasdaqGS:TSEM
NasdaqGS:TSEMSemiconductor

What Tower Semiconductor (TSEM)'s Electro‑Optic Polymer Deal Means For Shareholders

In early March 2026, Lightwave Logic announced a development agreement with Tower Semiconductor to integrate its electro‑optic polymer modulators into Tower’s PH18 silicon photonics platform, aiming to deliver compact, power‑efficient designs for next‑generation AI, data‑center, and high‑performance computing applications. An important aspect of this collaboration is that customers will be able to participate in multiple engineering tapeouts throughout 2026, potentially accelerating...
NYSE:DT
NYSE:DTSoftware

Reassessing Dynatrace (DT) Valuation After 20% One-Year Share Price Pullback

If you are wondering whether Dynatrace is attractively priced or not, the next few sections will walk through what the numbers are actually saying about the stock. Dynatrace shares last closed at US$38.02, with returns of 3.3% over 30 days, a 10.2% decline year to date and a 19.7% decline over the past year, which may have some investors reassessing both its growth potential and its risk profile. Recent headlines around Dynatrace have focused on its position in observability and application...
NYSE:CWEN.A
NYSE:CWEN.ARenewable Energy

Is Clearway Energy’s (CWEN.A) Share-Class Merger a Quiet Shift in Its Capital Allocation Story?

In March 2026, Clearway Energy, Inc. received board approval to seek shareholder consent to amend its charter and automatically convert each share of its Class A common stock into one share of Class C common stock, consolidating its public equity into a single share class after the 2026 annual meeting. The move is designed to simplify Clearway’s capital structure by eliminating the less liquid Class A line, potentially improving trading liquidity, broadening the investor base, and better...
NYSE:KRP
NYSE:KRPOil and Gas

Will Kimbell’s US$100 Million Buyback Shift Kimbell Royalty Partners' (KRP) Capital Return Narrative?

In early March 2026, Kimbell Royalty Partners, LP announced that its Board authorized a unit repurchase program of up to US$100,000,000, to be funded by cash on hand, free cash flow, or borrowings under its revolving credit facility, with any repurchased units to be retired and the authorization running through December 31, 2027. This multi-year buyback plan highlights management’s current emphasis on returning capital to unitholders and offers an additional lever for adjusting the...
NYSE:LAZ
NYSE:LAZCapital Markets

Lazard Shares Under Pressure As Liquidity Concerns Contrast With Valuation Upside

JPMorgan Chase has restricted lending to private credit providers after marking down some loans in its own portfolio. Following this move, Lazard (NYSE:LAZ) and other major financial firms have limited redemptions for certain funds to manage liquidity. The actions highlight fresh concerns about liquidity and stability across parts of the financial sector. Lazard, trading at $40.68, is being pulled into a wider industry story as investors react to tighter lending conditions and capped fund...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Assessing Zscaler (ZS) Valuation After Recent Share Price Weakness

Why Zscaler stock is drawing fresh attention Zscaler (ZS) shares have been under pressure recently, with negative returns over the past month, past 3 months, and year, putting the cloud security company back on many investors’ watchlists. See our latest analysis for Zscaler. At a latest share price of $151.61, Zscaler’s momentum has cooled, with a 30-day share price return of 13.04% and a year-to-date share price return decline of 31.26%, while the 3-year total shareholder return of 40.21%...
NYSE:NVO
NYSE:NVOPharmaceuticals

FDA Warning Tests Novo Nordisk Compliance And Reshapes NYSE NVO Risk Profile

U.S. FDA issues a serious warning letter to Novo Nordisk over failures to properly report postmarketing adverse drug events. Regulators cite missed or delayed disclosures of severe outcomes, including stroke and death, tied to certain medications. FDA instructs Novo Nordisk to provide additional corrective actions within 15 business days, signaling heightened scrutiny of its safety reporting processes. For investors watching NYSE:NVO, this warning lands at a time when the stock is trading...
NYSE:MAC
NYSE:MACRetail REITs

Is Macerich (MAC) Still Attractive After Recent Share Price Weakness And DCF Upside?

If you are wondering whether Macerich at around US$18.66 is offering real value today, or if the easy gains are already on the table, this article will walk through what the current price actually implies. The stock has seen a 5.8% decline over the last 7 days and a 3.7% decline over 30 days, yet it still shows a 0.8% return year to date and an 18.6% return over 1 year, with a very large 3 year return and a 73.9% return over 5 years. Recent moves in Macerich's share price come against a...
NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

Is GitLab (GTLB) Now Offering A Rare Opportunity After Steep Share Price Slide?

If you are wondering whether GitLab's share price now reflects a fair deal or an overreaction, you are not alone. That is exactly what this article will unpack. GitLab's stock has been under pressure recently, with a 10.1% decline over the last week, a 27.7% decline over the last month, a 36.9% decline year to date, and a 54.3% decline over the past year. These moves have kept GitLab on many investors' watchlists, as the company remains a key name in DevOps and cloud based software...
NasdaqGS:LITE
NasdaqGS:LITECommunications

Lumentum (LITE) Is Down 5.3% After NVIDIA’s $2 Billion Optics Bet And S&P 500 Inclusion

In early March 2026, NVIDIA announced multiyear agreements with Lumentum Holdings, including a US$2.00 billion investment and multibillion-dollar purchase commitments for advanced optical components, while Lumentum also issued 2,876,415 Series A Convertible Preferred shares to NVIDIA in a private placement to fund R&D and new U.S. manufacturing capacity. Shortly afterward, Lumentum was selected to join the S&P 500 index, underscoring how its optics technology has become central to...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

JD.com (JD) Is Up 9.7% After Loss-Funded Expansion And Major Buyback, Is The Story Changing?

In early March 2026, JD.com reported mixed fourth‑quarter and full‑year 2025 results, including quarterly net loss alongside higher annual revenue, while also confirming a US$0.50 per share dividend for 2025 and completing a US$3,000 million buyback of 183,200,000 shares, or 12.62% of its share count. Together, the swing to quarterly loss driven by heavy investment in new ventures and the sizeable capital return program highlight JD.com’s effort to balance growth spending with direct cash...
NasdaqGS:LNT
NasdaqGS:LNTElectric Utilities

Assessing Alliant Energy (LNT) Valuation After Earnings Beat And New $400 Million Credit Facility

Alliant Energy (LNT) has drawn fresh attention after reporting fourth quarter 2025 earnings and revenue above analyst expectations, alongside a new $400 million term loan facility that supports general corporate funding needs. See our latest analysis for Alliant Energy. The recent earnings beat, new credit facility and analyst attention come against a backdrop of improving momentum, with a 30 day share price return of 5.23% and a 1 year total shareholder return of 18.71%. If this utility news...
NYSE:COF
NYSE:COFConsumer Finance

Capital One’s Payment Push Tests Profitability And Liquidity Concerns

Capital One Financial (NYSE:COF) is working through the integration of its recently acquired Discover and Brex businesses as it pushes deeper into payment processing. The company is repositioning itself to compete more directly with established card networks, while its profitability and efficiency metrics, including ROE and ROA, have come under recent pressure. At the sector level, JPMorgan's move to limit lending to private credit providers has raised liquidity concerns that are weighing on...
NYSE:SWK
NYSE:SWKMachinery

Stanley Black And Decker Governance Vote Tests Confidence In Leadership Structure

A shareholder proposal is asking Stanley Black & Decker to permanently separate the CEO and Chairman roles. The company has recommended that investors vote against the proposal at its upcoming annual meeting. The debate focuses on board oversight, leadership structure, and how power is balanced at NYSE:SWK. For investors following NYSE:SWK, this governance dispute comes as the stock trades at $71.09, with a 5 year return of a 57.2% decline and a 30 day return of a 22.5% decline. Over the...
NYSE:WGO
NYSE:WGOAuto

Is Winnebago Industries (WGO) Now Attractive After Recent Share Price Slide

If you are wondering whether Winnebago Industries at around US$33.45 is a bargain or a value trap, you are not alone. This article focuses squarely on what the current price might be telling you. The stock has been under pressure recently, with a 12.1% decline over the last week and a 29.1% decline over the past month, while the 1 year return sits at 0.7% and the 5 year return at a 55.4% decline. Recent attention around Winnebago has focused on how demand for recreational vehicles fits into...
NYSE:PEN
NYSE:PENMedical Equipment

Is It Too Late To Consider Penumbra (PEN) After Strong 1 Year Share Price Gains?

If you are wondering whether Penumbra's current share price lines up with its underlying worth, you are not alone. This article is aimed squarely at that question. The stock last closed at US$334.99, with returns of 8.3% year to date and 28.5% over the past year, although the past week and month showed 1.7% and 1.2% declines respectively. Recent coverage around Penumbra has focused on its position in the medical devices space and how investors see its long term growth story. This helps frame...
NasdaqGS:EXE
NasdaqGS:EXEOil and Gas

How Insider Buying and Tech Partnerships Could Reshape Expand Energy’s (EXE) Investment Narrative

In recent months, Expand Energy has attracted fresh institutional money, insider share purchases from interim CEO Michael Wichterich, strong Q4 2025 results, and new technology partnerships with Leucipa, Baker Hughes, and Snowflake to improve efficiency and cut emissions. This combination of institutional support, insider conviction, and tech-enabled operational upgrades suggests investors are reassessing how the company is positioned within the U.S. natural gas landscape. Next, we’ll...
NasdaqGM:SOUN
NasdaqGM:SOUNSoftware

Assessing SoundHound AI (SOUN) Valuation After Recent Weak Returns And Strong Three Year Shareholder Gains

Event context and recent price performance SoundHound AI (SOUN) has drawn fresh attention after recent trading, with the share price closing at US$7.47 and posting negative returns over the past week, month, and past 3 months. See our latest analysis for SoundHound AI. While the recent 1 day, 7 day, 30 day, and 90 day share price returns have all been negative and suggest fading momentum around the current US$7.47 level, the 3 year total shareholder return of over 3x shows how volatile the...
NYSE:MDU
NYSE:MDUGas Utilities

Is MDU Resources Group (MDU) Pricing Look Stretched After Strong 1‑Year Share Gain?

If you are wondering whether MDU Resources Group at around US$20.90 is offering good value right now, you are not alone. This article will walk through what the current price might be implying. The stock has seen mixed recent moves, with a 1.7% decline over the last 7 days, a 2.9% gain over 30 days, a 5.2% gain year to date, and a 30.9% return over the past year, while the 3 year and 5 year returns are both a little over double the starting point. Recent headlines around MDU Resources Group...
NYSE:HPE
NYSE:HPETech

Assessing Hewlett Packard Enterprise (NYSE:HPE) Valuation After Earnings Beat And Raised Guidance

Earnings beat and higher guidance put Hewlett Packard Enterprise (HPE) in focus Hewlett Packard Enterprise (HPE) has drawn fresh attention after reporting quarterly revenue and earnings per share above expectations, backed by strong networking performance and AI related demand, and by lifting full year profit guidance. See our latest analysis for Hewlett Packard Enterprise. At a share price of $21.58, Hewlett Packard Enterprise has a 1 year total shareholder return of 50.04% and a 3 year...
NYSE:FERG
NYSE:FERGTrade Distributors

A Look At Ferguson Enterprises (FERG) Valuation After Strong Results And Cautious 2026 Outlook

Ferguson Enterprises (FERG) opened down 3.05% on March 9 after releasing strong results and positive 2026 guidance, as investors focused on weaker U.S. residential trends and a 1% decline in HVAC revenues. See our latest analysis for Ferguson Enterprises. That 5.14% one day share price decline, together with a 16.73% 30 day share price return, points to fading short term momentum. However, the 44.60% one year total shareholder return remains strong. If Ferguson’s latest move has you...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

Early VOXZOGO Data May Reshape BioMarin Growth Expectations In Achondroplasia

BioMarin Pharmaceutical (NasdaqGS:BMRN) reported new multi year data on VOXZOGO in young children with achondroplasia. The results, from clinical and real world studies, indicate durable gains in skeletal growth and body proportionality when treatment begins before age 2. The data set is being presented at a major clinical genetics conference, highlighting its relevance for both clinicians and patient communities. BioMarin focuses on therapies for rare genetic conditions, and VOXZOGO is a...
NasdaqGS:CSCO
NasdaqGS:CSCOCommunications

What Cisco Systems (CSCO)'s AI Demand Strength but Margin Pressure Means For Shareholders

Cisco Systems recently presented across several high-profile events, including Mobile World Congress 2026 and Morgan Stanley’s TMT Conference, where management highlighted strong fiscal Q2 2026 demand in AI infrastructure, networking, and security alongside double-digit order growth across regions. However, investors have grown concerned that below-expectation gross margins, memory cost inflation, and cautious forward guidance may limit the benefit of this AI and networking momentum for...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

What Vertex Pharmaceuticals (VRTX)'s IgA Nephropathy Win Means For Its Next Major Franchise Potential

Vertex Pharmaceuticals recently reported that its engineered fusion protein povetacicept met the primary and key secondary endpoints in a Phase 3 RAINIER interim analysis for IgA nephropathy, showing large reductions in urine protein and disease‑related antibodies with a generally manageable safety profile. The company is moving quickly to complete a rolling Biologics License Application for potential accelerated FDA approval, positioning povetacicept as a possible fourth major franchise...